Company Tatva Chintan Pharma Chem Limited Bombay S.E.
Equities
TATVA
INE0GK401011
Specialty Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,115 INR | +1.46% | -3.24% | -30.40% |
Business Summary
Number of employees: 608
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Phase Transfer Catalysts
34.0
%
| 980 | 22.7 % | 1,432 | 34.0 % | +46.09% |
Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals
31.7
%
| 1,028 | 23.8 % | 1,335 | 31.7 % | +29.93% |
Structure Directing Agents
30.3
%
| 2,248 | 52.1 % | 1,276 | 30.3 % | -43.23% |
Electrolyte Salts
3.9
%
| 57 | 1.3 % | 165 | 3.9 % | +190.92% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
72.3
%
| 3,405 | 78.9 % | 3,042 | 72.3 % | -10.64% |
India
27.7
%
| 908 | 21.1 % | 1,167 | 27.7 % | +28.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 12/96/12 | |
Ashok Bothra
DFI | Director of Finance/CFO | - | 03/21/03 |
Chief Administrative Officer | - | 21/15/21 | |
Chief Operating Officer | - | 12/17/12 | |
Ajay Singh Rawat
CTO | Chief Tech/Sci/R&D Officer | - | 05/19/05 |
Compliance Officer | - | 17/22/17 | |
Rakesh Poonia
PRN | Corporate Officer/Principal | - | 17/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 27/21/27 | |
Chief Executive Officer | 51 | 12/96/12 | |
Director/Board Member | 52 | 12/96/12 | |
Director/Board Member | 50 | 12/96/12 | |
Director/Board Member | 70 | 27/21/27 | |
Director/Board Member | 51 | 27/21/27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,392,055 | 6,545,097 ( 27.98 %) | 0 | 27.98 % |
Company contact information
Tatva Chintan Pharma Chem Ltd.
GIDC Estate Plot No 502/17
393002, Ankleshwar
+91 75 7484 8533
http://www.tatvachintan.comSales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.80% | 66.73B | |
+2.92% | 49.79B | |
+19.98% | 42.5B | |
+20.88% | 26.45B | |
+12.04% | 19.66B | |
+1.27% | 17.18B | |
-22.98% | 15.82B | |
+2.77% | 15.56B | |
-9.25% | 15.41B |
- Stock Market
- Equities
- TATVA Stock
- TATVA Stock
- Company Tatva Chintan Pharma Chem Limited